Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-16,453
Closed -$32.7K 1950
2025
Q2
$32.7K Sell
16,453
-3,762
-19% -$6.88K ﹤0.01% 1783
2025
Q1
$29.3K Sell
20,215
-2,280
-10% -$4.21K ﹤0.01% 1576
2024
Q4
$46.6K Buy
22,495
+9,344
+71% +$17.5K ﹤0.01% 1297
2024
Q3
$23.1K Buy
+13,151
New +$33.7K ﹤0.01% 1147

IEQ Capital's HLVX Position: Q3 2025 in Review

IEQ Capital sold out of HilleVax (HLVX) in Q3 2025, closing a stake of 16,453 shares — an estimated $32.7K sold.

IEQ Capital first reported a position in HLVX in Q3 2024 and held it in 4 quarters. The position peaked at $46.6K in Q4 2024. 1 fund tracked by Wall St. Rank holds HLVX as of Q3 2025.

  • IEQ Capital reported no remaining HilleVax position as of Q3 2025 after selling out during the quarter.
  • IEQ Capital sold 16,453 HilleVax shares in Q3 2025, an estimated $32.7K.
  • IEQ Capital first reported a position in HilleVax in Q3 2024 and held it in 4 quarters.
  • IEQ Capital's HilleVax position peaked at $46.6K in Q4 2024.
  • 1 fund tracked by Wall St. Rank held HilleVax as of Q3 2025.

Based on IEQ Capital's 13F filing for Q3 2025, filed 14 Nov 2025.